BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33235496)

  • 1. GJA1 is a Prognostic Biomarker and Correlated with Immune Infiltrates in Colorectal Cancer.
    Hu W; Li S; Zhang S; Xie B; Zheng M; Sun J; Yang X; Zang L
    Cancer Manag Res; 2020; 12():11649-11661. PubMed ID: 33235496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PSMC5 Promotes Proliferation and Metastasis of Colorectal Cancer by Activating Epithelial-Mesenchymal Transition Signaling and Modulating Immune Infiltrating Cells.
    He Z; Yang X; Huang L; Zhou L; Zhang S; Sun J; Zheng M; Ma J; Feng B; Zang L
    Front Cell Dev Biol; 2021; 9():657917. PubMed ID: 34336824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SEMA6B Overexpression Predicts Poor Prognosis and Correlates With the Tumor Immunosuppressive Microenvironment in Colorectal Cancer.
    Li T; Yan Z; Wang W; Zhang R; Gan W; Lv S; Zeng Z; Hou Y; Yang M
    Front Mol Biosci; 2021; 8():687319. PubMed ID: 34938771
    [No Abstract]   [Full Text] [Related]  

  • 4. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.
    Wei C; Yang C; Wang S; Shi D; Zhang C; Lin X; Liu Q; Dou R; Xiong B
    Mol Cancer; 2019 Mar; 18(1):64. PubMed ID: 30927925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
    Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
    Front Immunol; 2019; 10():6. PubMed ID: 30761122
    [No Abstract]   [Full Text] [Related]  

  • 6. Mapk14 is a Prognostic Biomarker and Correlates with the Clinicopathological Features and Immune Infiltration of Colorectal Cancer.
    Wang D; Peng L; Hua L; Li J; Liu Y; Zhou Y
    Front Cell Dev Biol; 2022; 10():817800. PubMed ID: 35141222
    [No Abstract]   [Full Text] [Related]  

  • 7. Tumor-Infiltrating Immune Cells Act as a Marker for Prognosis in Colorectal Cancer.
    Ye L; Zhang T; Kang Z; Guo G; Sun Y; Lin K; Huang Q; Shi X; Ni Z; Ding N; Zhao KN; Chang W; Wang J; Lin F; Xue X
    Front Immunol; 2019; 10():2368. PubMed ID: 31681276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GJA1 Expression and Its Prognostic Value in Cervical Cancer.
    Meng S; Fan X; Zhang J; An R; Li S
    Biomed Res Int; 2020; 2020():8827920. PubMed ID: 33299882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follistatin-Like 3 Correlates With Lymph Node Metastasis and Serves as a Biomarker of Extracellular Matrix Remodeling in Colorectal Cancer.
    Yang C; Cao F; Huang S; Zheng Y
    Front Immunol; 2021; 12():717505. PubMed ID: 34335633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CMTM6 and PD-L1 coexpression is associated with an active immune microenvironment and a favorable prognosis in colorectal cancer.
    Peng QH; Wang CH; Chen HM; Zhang RX; Pan ZZ; Lu ZH; Wang GY; Yue X; Huang W; Liu RY
    J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33579737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LIMK1: A promising prognostic and immune infiltration indicator in colorectal cancer.
    Liu X; Song Q; Wang D; Liu Y; Zhang Z; Fu W
    Oncol Lett; 2022 Jul; 24(1):234. PubMed ID: 35720504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long Noncoding RNA KCNQ1OT1 is a Prognostic Biomarker and mediates CD8
    Lin ZB; Long P; Zhao Z; Zhang YR; Chu XD; Zhao XX; Ding H; Huan SW; Pan YL; Pan JH
    Int J Biol Sci; 2021; 17(7):1757-1768. PubMed ID: 33994860
    [No Abstract]   [Full Text] [Related]  

  • 13. The Prognostic Significance of RIMKLB and Related Immune Infiltrates in Colorectal Cancers.
    Cao Y; Deng S; Yan L; Gu J; Mao F; Xue Y; Qin L; Jiang Z; Cai W; Zheng C; Nie X; Liu H; Sun Z; Shang F; Tao K; Wang J; Wu K; Zhu B; Cai K
    Front Genet; 2022; 13():818994. PubMed ID: 35444692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large tumor suppressor 2 is a prognostic biomarker and correlated with immune infiltrates in colorectal cancer.
    Zhao C; Chen J; Liu Y; Ju S; Wang G; Wang X
    Bioengineered; 2021 Dec; 12(2):11648-11661. PubMed ID: 34699318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of
    Li N; Zhou Z; Zhang L; Tang H; Chen X; Zhou H
    Transl Cancer Res; 2022 May; 11(5):981-992. PubMed ID: 35706814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of Nicotinamide N-methyltransferase mainly covers stroma of colorectal cancer and correlates with unfavorable survival by its product 1-MNA.
    Yang J; Tong Q; Zhang Y; Yuan S; Gao Y; Deng K; Wang Y; Lu J; Xie X; Zhang Z; Zhang J
    J Cancer; 2021; 12(20):6170-6181. PubMed ID: 34539890
    [No Abstract]   [Full Text] [Related]  

  • 17. Transcriptomic Analysis Identifies Complement Component 3 as a Potential Predictive Biomarker for Chemotherapy Resistance in Colorectal Cancer.
    He XS; Zou SY; Yao JL; Yu W; Deng ZY; Wang JR; Gan WJ; Wan S; Yang XQ; Wu H
    Front Mol Biosci; 2021; 8():763652. PubMed ID: 34722636
    [No Abstract]   [Full Text] [Related]  

  • 18. Tumor cell-derived SPON2 promotes M2-polarized tumor-associated macrophage infiltration and cancer progression by activating PYK2 in CRC.
    Huang C; Ou R; Chen X; Zhang Y; Li J; Liang Y; Zhu X; Liu L; Li M; Lin D; Qiu J; Liu G; Zhang L; Wu Y; Tang H; Liu Y; Liang L; Ding Y; Liao W
    J Exp Clin Cancer Res; 2021 Sep; 40(1):304. PubMed ID: 34583750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The possible role of SRMS in colorectal cancer by bioinformatics analysis.
    Zhang J; Liu W; Feng S; Zhong B
    World J Surg Oncol; 2021 Nov; 19(1):326. PubMed ID: 34781983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. THBS1 facilitates colorectal liver metastasis through enhancing epithelial-mesenchymal transition.
    Liu X; Xu D; Liu Z; Li Y; Zhang C; Gong Y; Jiang Y; Xing B
    Clin Transl Oncol; 2020 Oct; 22(10):1730-1740. PubMed ID: 32052380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.